Post by PharmaShots

Kashiv BioSciences LLC’s MAA for ADL-018, a proposed biosimilar to Xolair (Omalizumab), accepted by Health Canada, advancing efforts to expand access to cost-effective biologic therapies in Canada Subscribe to our weekly newsletter and never miss a beat: https://lnkd.in/gTU62Zbz #KashivBioSciences #ADL018 #HealthCanada #Biosimilar #Xolair #Omalizumab #Alvotech https://lnkd.in/gTNfJCtq